MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.alit.2019.10.011

Медицинская библиотека · Allergology international : official journal of the Japanese Society of Allergology · 2019

Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency.

Tiotiu Angelica, Salvator Hélène, Jaussaud Roland, Jankowski Roger, Couderc Louis-Jean, Catherinot Emilie, Devillier Philippe

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Although antibody deficiency (AD) is a well-known cause of recurrent respiratory infections, there are few data on its impact in adults with asthma. The objective of the present study was to assess outcomes in adults with severe asthma and AD after treatment with either azithromycin or subcutaneous immunoglobulins (SCIg).

METHODS

We performed a 5-year, prospective, observational, two-centre study of adults with severe asthma and AD in France. Bronchiectasis was ruled out by high-resolution computed tomography. Patients were treated for one year with either azithromycin (250 mg every other day) or SCIg (0.4-0.6 g/kg/months, weekly). All patients were evaluated for exacerbations, asthma control and lung function at baseline and then one year after treatment initiation.

RESULTS

Thirty-nine patients with severe asthma were included in the study: 14 had been treated with azithromycin and 25 had been treated with SCIg. Before the initiation of treatment for AD, all patients had an Asthma Control Questionnaire (ACQ-7) score > 1.5 (mean ± SD: 2.71 ± 0.53) despite treatment at GINA step 4 or 5, and had a high exacerbation rate requiring oral corticosteroids and/or rescue antibiotics (∼7.2 ± 2.1/patient/year). One year after treatment initiation, we observed a significantly higher FEV1 (mean: 0.18 ± 0.22 L) and ACQ-7 score (1.26 ± 0.68), and a significantly lower exacerbation rate (1.63 ± 1.24/patient/year).

CONCLUSIONS

Treatment of AD dramatically improved asthma outcomes - suggesting that adults with severe asthma and recurrent respiratory infections should be screened and (if appropriate) treated for AD.

Для цитирования: Tiotiu Angelica, Salvator Hélène, Jaussaud Roland, Jankowski Roger, Couderc Louis-Jean, Catherinot Emilie, Devillier Philippe. Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency.. Allergology international : official journal of the Japanese Society of Allergology. 2019. DOI: 10.1016/j.alit.2019.10.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.